Columbia Biomedical Engineering Technology Accelerator
ForecastedInternal — Columbia University only
Columbia Biomedical Engineering Technology Accelerator supports clinician, engineer, and scientist teams translating biomedical technologies into clinical solutions ready for commercial investment.
Funder: Columbia University
Due Dates (Anticipated): January 2027 (Application deadline)
Funding Amounts: Up to $100,000 per project for up to 12 months
Summary: Supports teams translating Columbia biomedical technologies into clinical solutions and positioning them for commercial investment.
Key Information: Teams must include an engineer or scientist and a practicing clinician, with at least one Columbia faculty member and technology based on Columbia intellectual property.
Description
The Columbia Biomedical Engineering Technology Accelerator, formerly the Columbia-Coulter Translational Research Partnership, provides funding, education, resources, and mentorship to clinician, engineer, and scientist teams developing solutions to unmet clinical needs. Run at Columbia University, the program aims to move promising biomedical technologies out of the laboratory and into patient care. Awards support specific tasks that validate a commercial hypothesis rather than a scientific hypothesis, bridging the gap to commercial investment.
The accelerator helps teams reduce technical and commercial risk through determinative experiments, regulatory planning, intellectual property guidance, and early engagement with potential development partners. Selected teams receive marketing, regulatory, reimbursement, and legal resources alongside expert mentorship. Technologies with a path to market in less than seven years are especially relevant.
